Several other research firms also recently weighed in on SREN. UBS Group set a CHF 88.50 price target on Swiss Re and gave the stock a sell rating in a research note on Friday, August 30th. Deutsche Bank set a CHF 108 price target on Swiss Re and gave the stock a neutral rating in a research note on Wednesday, July 31st. Credit Suisse Group set a CHF 116 price target on Swiss Re and gave the stock a buy rating in a research note on Thursday, August 8th. JPMorgan Chase & Co. set a CHF 120 price target on Swiss Re and gave the stock a buy rating in a research note on Wednesday, July 31st. Finally, HSBC set a CHF 115 target price on Swiss Re and gave the stock a buy rating in a research note on Monday, June 3rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and seven have assigned a buy rating to the company. Swiss Re presently has a consensus rating of Buy and an average target price of CHF 105.33.
Swiss Re has a 12 month low of CHF 81.65 and a 12 month high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Story: Cost of Capital Explained
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.